Filing Details

Accession Number:
0000899243-18-011028
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-01 17:14:10
Reporting Period:
2018-04-27
Accepted Time:
2018-05-01 17:14:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1521036 Lantheus Holdings Inc. LNTH In Vitro & In Vivo Diagnostic Substances (2835) 352318913
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1610664 Cesare Orlandi C/O Lantheus Holdings, Inc.
331 Treble Cove Road
North Billerica MA 01862
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-04-27 6,901 $18.00 97,216 No 4 S Direct
Common Stock Disposition 2018-04-27 1,300 $18.03 95,916 No 4 S Direct
Common Stock Disposition 2018-04-30 600 $18.00 95,316 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2018.